Ligand validation:5CCL

SAM: S-ADENOSYLMETHIONINE

SAM is a Ligand Of Interest in 5CCL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5CCL_SAM_A_504	97%	43%	0.066	0.978	0.96	1.23	1	2	0	0	100%	1
6PAF_SAM_A_508	99%	44%	0.06	0.988	0.95	1.19	2	2	0	0	100%	1
6P7Z_SAM_A_506	97%	41%	0.072	0.989	1.06	1.22	2	2	0	0	100%	1
5V37_SAM_A_504	97%	34%	0.065	0.977	1.15	1.46	1	3	0	0	100%	1
6P6K_SAM_A_507	96%	36%	0.07	0.981	1.16	1.36	2	1	0	0	100%	1
3QWP_SAM_A_510	96%	33%	0.065	0.975	1.06	1.57	1	4	0	0	100%	1
2P02_SAM_A_2	100%	41%	0.038	0.988	0.67	1.61	-	3	0	0	100%	1
8XAM_SAM_B_402	100%	44%	0.041	0.984	0.88	1.26	-	3	0	0	100%	1
5LSA_SAM_A_303	100%	33%	0.046	0.986	0.91	1.73	-	4	2	0	100%	1
8QE3_SAM_A_402	99%	62%	0.047	0.984	0.6	0.84	-	2	0	0	100%	1
4IV0_SAM_B_302	99%	37%	0.051	0.986	1.1	1.37	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.